Geode Capital Management
STIM icon

Geode Capital Management’s Neuronetics STIM Stock Holding History

Geode Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Sell
458,474
-500,515
-52% -$728K ﹤0.01% 3529
2026
Q1 		$1.39M Buy
958,989
+67,256
+8% +$107K ﹤0.01% 3253
2025
Q4 		$1.23M Buy
891,733
+14,799
+2% +$31K ﹤0.01% 3315
2025
Q3 		$2.39M Sell
876,934
-2,111
-0.2% -$7.5K ﹤0.01% 3114
2025
Q2 		$3.07M Buy
879,045
+556,268
+172% +$2.2M ﹤0.01% 2979
2025
Q1 		$1.19M Buy
322,777
+8,701
+3% +$31.8K ﹤0.01% 3247
2024
Q4 		$506K Buy
314,076
+8,466
+3% +$8.8K ﹤0.01% 3596
2024
Q3 		$232K Buy
305,610
+7,540
+3% +$9.9K ﹤0.01% 3859
2024
Q2 		$537K Buy
298,070
+11,426
+4% +$33K ﹤0.01% 3546
2024
Q1 		$1.36M Buy
286,644
+21,040
+8% +$73.9K ﹤0.01% 3247
2023
Q4 		$770K Buy
265,604
+15,865
+6% +$25K ﹤0.01% 3448
2023
Q3 		$337K Buy
249,739
+201
+0.1% +$352 ﹤0.01% 3766
2023
Q2 		$537K Sell
249,538
-6,275
-2% -$15.2K ﹤0.01% 3611
2023
Q1 		$744K Buy
255,813
+26,204
+11% +$132K ﹤0.01% 3483
2022
Q4 		$1.58M Buy
229,609
+9,726
+4% +$45.9K ﹤0.01% 3152
2022
Q3 		$699K Buy
219,883
+3,044
+1% +$11.1K ﹤0.01% 3565
2022
Q2 		$696K Sell
216,839
-176,427
-45% -$512K ﹤0.01% 3575
2022
Q1 		$1.19M Sell
393,266
-2,990
-0.8% -$10.1K ﹤0.01% 3532
2021
Q4 		$1.77M Buy
396,256
+94,363
+31% +$462K ﹤0.01% 3424
2021
Q3 		$1.98M Sell
301,893
-75,707
-20% -$726K ﹤0.01% 3357
2021
Q2 		$6.05M Buy
377,600
+212,430
+129% +$2.94M ﹤0.01% 2784
2021
Q1 		$2.04M Buy
165,170
+67,031
+68% +$1.03M ﹤0.01% 3243
2020
Q4 		$1.09M Buy
98,139
+20,918
+27% +$157K ﹤0.01% 3344
2020
Q3 		$375K Sell
77,221
-241
-0.3% -$914 ﹤0.01% 3514
2020
Q2 		$149K Sell
77,462
-83,392
-52% -$171K ﹤0.01% 3747
2020
Q1 		$304K Buy
160,854
+16,069
+11% +$50.2K ﹤0.01% 3422
2019
Q4 		$650K Buy
144,785
+17,095
+13% +$106K ﹤0.01% 3423
2019
Q3 		$1.06M Buy
127,690
+311
+0.2% +$3.4K ﹤0.01% 3212
2019
Q2 		$1.59M Buy
127,379
+19,055
+18% +$269K ﹤0.01% 3073
2019
Q1 		$1.65M Buy
108,324
+34,754
+47% +$575K ﹤0.01% 2963
2018
Q4 		$1.42M Buy
73,570
+13,033
+22% +$286K ﹤0.01% 2947
2018
Q3 		$1.94M Buy
+60,537
New +$1.84M ﹤0.01% 2899

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's STIM Position: Q2 2026 in Review

Geode Capital Management reduced its Neuronetics (STIM) stake by 52% in Q2 2026, selling an estimated $728K and leaving 458,474 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #3529.

Geode Capital Management first reported a position in STIM in Q3 2018 and has held it in 32 quarters since. The position peaked at $6.05M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Geode Capital Management held 458,474 shares of Neuronetics worth $596K as of Q2 2026.
  • Geode Capital Management sold 500,515 Neuronetics shares in Q2 2026, an estimated $728K.
  • Neuronetics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3529 holding.
  • Geode Capital Management first reported a position in Neuronetics in Q3 2018 and has held it in 32 quarters since.
  • Geode Capital Management's Neuronetics position peaked at $6.05M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.